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b s t r a c t
e report on the in vitro response of human gingival fibroblasts (HGF-1 cell line) to various thin films
f titanium dioxide (TiO2) deposited on titanium (Ti) substrates by low pressure metal-organic chemical
apor deposition (LP-MOCVD). The aimwas to study the influenceof filmstructural parameters on the cell
ehavior comparatively with a native-oxide covered titanium specimen, this objective being topical and
nteresting formaterials applications in implantology.HGF-1 cellswere culturedon three LP-MOCVDpre-
ared thin films of TiO2 differentiated by their thickness, roughness, transversal morphology, allotropic
omposition and wettability, and on a native-oxide covered Ti substrate. Besides traditional tests of cell
iability andmorphology, the biocompatibility of thesematerialswas evaluated byfibronectin immunos-
aining, assessment of cell proliferation status and the zymographic evaluation of gelatinolytic activities
pecific tomatrixmetalloproteinases secreted by cells grown in contactwith studied specimens. The ana-
yzed surfaces proved to influence fibronectin fibril assembly, cell proliferation and capacity to degrade
xtracellular matrix without considerably affecting cell viability and morphology. The MOCVD of TiO2
roved effective in positively modifying titanium surface for medical applications. Surface properties
y, thelaying a crucial role for cell behavior were the wettability and, secondaril
referring a moderately rough and wettable TiO2 coating.
. Introduction
Nowadays, biomaterials are used in a different way compared
o just a decade ago. Despite this fact, implantable medical devices
re still important, and medical technologies and tissue engineer-
ng still encompass bioinert metals, activated or/and bioactivated,
aking into account that expectations of their performance also
ave been changed [1]. In this context, Ti and Ti alloys are the
ost commonly used metal materials to manufacture orthope-
ic and dental implants owing to its excellent physical, chemical,
echanical properties, and biocompatibility with receiving liv-
ng tissues after implantation [2]. An essential surface feature
f Ti is the capacity to spontaneously form a stable amorphous
iO2 film under exposure to the atmosphere and/or physiolog-
cal fluids. This passive, 4–6nm thick film [3] protects Ti from
orrosion, delays the release of Ti ions [4,5], and promotes a favor-
ble osseointegration. In dentistry, the passive TiO2 film formed
n titanium seems to be more stable and protective than that
∗ Corresponding author at: ENSIACET, 4 allée Emile Monso, BP-44362, 31432,
oulouse Cedex 4, France. Tel.: +33 5 34 32 34 39; fax: +33 5 34 32 34 98.
E-mail address: alain.gleizes@ensiacet.fr (A.N. Gleizes).
oi:10.1016/j.matchemphys.2010.10.028roughness, HGF-1 cells
formed on the Ti alloys, usually used in other medical applica-
tions.
The evolution of biocompatibility concept [6] is based on the
idea that the response to specific individual materials could vary
from one application to another, biocompatibility being dependent
on the material characteristics but only in a specific application. In
such a way, dental implants are unique in the body when com-
pared to other medical implant types, in that they create two
interfaces: the implant bone interface (at the radicular portion of
the implant) and the gingival tissue implant interface. The main-
tenance of this last interface seems to be as important as bone
maintenance adjacent to the implant. The area of gingival tissue
at the point where the natural tooth emerges from the bone has
to regenerate around the neck of an implant in order to protect
the underlying connective tissue and to prevent the implant from
moving and loosening eventually. Thus, the response of gingival
epithelial and connective tissue cells to implant surface is very
important.The long-term success of implants most importantly requires
stable interfacial interactions between biomaterial and the
surrounding tissue. Therefore, different surface modification
approaches have been attempted to improve the bioactive bone-
binding capacity of titanium metal [6–13]. They have been applied
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sspecially to form a bioactive TiO2 layer on the metal sur-
ace.
A technique that has scarcely been applied to the deposition
f titanium dioxide for clinical purposes is metal-organic chemi-
al vapor deposition (MOCVD) [14–16]. This technique is widely
sed to prepare TiO2 thin films at relatively low temperature. It is
ell adapted to the coating of complex-shaped surfaces, especially
t low pressure. The microstructural parameters (crystallinity,
rowth mode, grain size, texture, roughness, allotropic composi-
ion, surface energy. . .) of the deposit prepared byMOCVD sensibly
epends on the numerous experimental parameters of the tech-
ique, mainly: surface state of the substrate, growth temperature,
otal pressure, partial pressure and molar fraction of the precursor,
ime of deposition. Therefore varied surface microstructures can
e obtained just by playing with the parameters. The MOCVD tech-
ique thus offers the possibility to study the influence of various
urface structure parameters on the biocompatibility of cells.
To our knowledge, the few studies devoted to the elucidation
f in vitro interactions of the cells with TiO2 in different physical
tates deal with TiO2 particles blasted on Ti substrates [17], oxide
ayers prepared by MOCVD [11,14–16] or anodic oxidation [18,19],
luster-assembled nanostructured TiO2 films [20], and sol–gel-
erived titanium oxide [21,22].
In this context, thepresent studywasundertaken toevaluate the
iocompatibility of various TiO2 thin films deposited on titanium
ubstrates using MOCVD technique. Biocompatibility was evalu-
ted in culture of human gingival fibroblasts, by addressing cell
iability, cytomorphology, adhesive cell-biomaterial interactions
ediated through fibronectin (FN) matrix, proliferation capacity
nd potential for degradation of the extracellular matrix (ECM), as
ndicators of the biological performance of studied materials.
. Experimental
.1. Preparation of materials
The substrateswere pure Ti discs of 1mm thickness and 10mmdiameter (99.6%
urity, Good Fellow Ltd.). Deposition surfaces were mechanically polished with
80-grit SiC-paper. Before TiO2 deposition, the discs were ultrasonically cleaned
n acetone, then in boiling alcohol, and rinsed with distilled water. Control discs
ere cleaned in the same way and used as covered with their native oxide. TiO2
hin films were grown using LP-MOCVD with titanium tetra-isopropoxide (TTIP) as
precursor, and nitrogen as both carrier and dilution gas. The procedure and the
xperimental set-up were described in a previous paper [10].
Deposition parameters were: TTIP temperature, 25 ◦C; N2 flow in the precursor
ontainer, 20 sccm; dilution N2 flow, 575 sccm; total pressure, 20Torr; TTIP molar
raction in thegasphase, 76×10−6; deposition temperature, 400 ◦C;deposition time
anging from 90 to 360min to vary deposit thickness.
.2. Characterization of TiO2 films
The three LP-MOCVD TiO2-coated Ti samples prepared for this study are char-
cterized by the following parameters: (1) film thickness, deduced from the weight
f deposited TiO2; (2) film transversal morphology, examined with a LEO-435 scan-
ing electronmicroscope (SEM) operating at 15kV; (3) roughness (Ra),measured on
.5mm2 of samples surface area with an optical interferometer MetroProTM, Zygo
ew View 100 equipment; (4) water contact angles measured with a DIGIDROP
ontact Angle Meter (GBX Scientific Instruments).
Deposited phases were identified from X-ray diffraction patterns recorded with
vertical, theta-theta geometry diffractometer (Seifert XRD3000 TT) equippedwith
graphite monochromator and a Cu anticathode ( CuK1 = 1.5406 A˚). Both grazing
ncidence X-ray diffraction (GIXRD) patterns (grazing angle of 2◦) and – patterns
ere recorded.
.3. Cells and cell culture conditionsHGF-1 cells (American Type Culture Collection)were seeded on TiO2-coated and
ative-oxide covered Ti discs, placed into Permanox Lab-TekChamber Slides (Nunc),
t an initial densityof1.2×104 cells cm−2. Theyweregrown inaDulbecco’sModified
agle Medium (DMEM) containing 10% (v/v) fetal bovine serum (FBS) at 37 ◦C in a
tandard incubator with 5% CO2 in air. Prior to cell culture, all these materials were
terilized at 180 ◦C for 30min. All experiments were repeated 3 times.2.4. Assay of cell viability
The eventual toxic effects of the analyzed specimens on cultured gingival fibrob-
lastswere evaluatedbydetecting lactate dehydrogenase (LDH) activity released into
the media as a marker of cell death and plasma membrane lysis. This study was per-
formed in triplicate samples from the cell culture media maintained in contact with
TiO2-coated andnative-oxide covered Ti discs for 72h, by using a cytotoxicity detec-
tion kit (TOX-7, Sigma–Aldrich Co.) according to the manufacturer’s protocol. High
OD490nm values are indicative of a reduction in the cell viability.
2.5. Immunocytochemical staining of actin and fibronectin
At the end of the incubation period (72h and, respectively, 120h for studies
of actin and fibronectin expression), cells were fixed with 4% paraformaldehyde
in PBS for 20min and observed by phase contrast microscopy. Staining of actin
was performed with fluorescein isothiocyanate (FITC)–phalloidin (20gmL−1;
Sigma–Aldrich Co.) at 37 ◦C for 1h. Before this, they were permeabilized for 15min
with 0.1% Triton X-100/2% BSA and washed in PBS. For FN visualization, fixed and
permeabilized specimens were incubated with anti-FN (mouse) primary antibody
(EP5 clone from Santa Cruz Biotechnology, dilution 1:50) for 2h, and then incubated
with anti-mouse secondary antibody labeled with FITC (Santa Cruz Biotechnology,
dilution 1:200) for 1h. In this case, the nuclei were counterstained with DAPI to
reveal cell density.
All the Ti specimens were viewed with an inverted fluorescent microscope
Olympus IX71. Excitation wavelengths were 495nm for FITC and 358nm for DAPI.
The images were captured by means of Cell F image acquiring system.
2.6. BrdU immunocytochemistry
After 6h treatment of HGF-1 cells (at 24h post-seeding) with 5-bromo-2′-
deoxyuridine (BrdU) at a final concentration of 10M,TiO2-coated andnative-oxide
covered Ti discs were maintained in 4% paraformaldehyde for 20min. To enable
antibody binding to the incorporated BrdU into the DNA of dividing cells, cells were
permeabilizedwith1%TritonX-100and theDNAwasdenaturedby sequential treat-
mentwith 1NHCl (20min on ice) and 2NHCl (10min at room temperature and then
40min at 37 ◦C). After washing in borate buffer (0.1M, pH 8.5) and blocking with 1%
TritonX-100/5%BSA, sampleswere incubated for 2hwith amonoclonalmouse anti-
BrdU antibody (Sigma–Aldrich Co.) diluted 1:100. Antibody binding was detected
by incubating discs for 1h at room temperature with FITC-conjugated goat anti-
mouse IgG (Santa Cruz Biotechnology) used at 1:100 dilution. After washing with
PBS, samples were examined under an inverted fluorescent microscope Olympus
IX71.
In this study and in the immunocytochemical assays, previously presented, neg-
ative controls were realized by substitution of the primary antibodies with PBS.
At least 10 fields from three independent experiments were examined.
2.7. Western blot assay
Total cell lysates containing 30g protein, as determined by Bradford method
[23], were separated by SDS-PAGE on 10% polyacrylamide gels. After electrophore-
sis, proteins from the gel were transferred to nitrocellulose membranes (Invitrogen
0.45m pore nitrocellulose/filter paper sandwich; XCell IITM Blot Module). Mem-
branes were blocked with 5% nonfat milk, and probed with proliferating cell nuclear
antigen (PCNA)mousemonoclonal antibody (1:200) for at least 2h. Inorder todetect
the antibodies which have bound, the membranes were incubated with alkaline
phosphatase-conjugated goat anti-mouse IgG (1:7500) for 1h, and developed with
NBT/BCIP solution. The blots were reprobed with anti--actin antibody to confirm
equal protein loading. Both primary and secondary antibodies were purchased from
Santa Cruz Biotechnology.
2.8. Gelatin zymography
Gelatin zymographywas performed by using amodification of the procedure by
Cimpean et al. [24]. Briefly, aliquots (20g protein) of conditioned culture medium,
maintained in contact for 72h with the sub-confluent cultures, were subjected to
SDS-PAGE in 7.5% (w/v) polyacrylamide gels impregnated with 1mgmL−1 gelatin
under non-reducing conditions.
After electrophoresis, gels were washed two times for 30min each in a buffer
containing 50mM Tris–HCl (pH 7.6), 50mM NaCl, 10mM CaCl2, 0.05% Brij 35 and
2.5%TritonX-100and then incubated for18hat37 ◦Cwith the samebuffer excluding
Triton X-100. After incubation, the gels were stained with 0.1% Coomassie Brilliant
Blue-R 250 and then destained in acetic acid: methanol: water (1:2:7). Matrix met-
alloproteinase (MMP) specific gelatinolytic activities were detected as clear bands
against a background of blue stained, intact gelatin impregnated acrylamide gel.2.9. Statistical analysis
Statistical analysis of surface roughness and the LDH assay was performed with
GraphPrism software using one-wayANOVAwith Bonferroni’smultiple comparison
tests.
Table 1
A summary of TiO2 films properties.
Specimen code T-1200 T-9 T-12 T-14
Deposition time (min) No 90 250 360
Thickness (nm) A few nm thin native oxide layer 200 600 1000
Transversal morphology Compact Compact Compact undercoat + thin columnar overlay Columnar
Roughness Ra (m)a 0.35 (0.02) 0.71 (0.01) 0.75 (0.04) 0.92 (0.14)
Contact angle (◦) 60 55 9 8
Phasesb Amorphous A–R a–R A–R
ificant
T
3
3
t
F
(a Standard deviations are given in parentheses. Mean values are statistically sign
1200).
b A (a) =majority (minority) of anatase; R (r) =majority (minority) of rutile.
. Results and discussion.1. Characterization of TiO2 films
It is well known that host tissues specifically interact with
he outermost layer of an implant [25]. Thus, when a Ti implant
ig. 1. Surface micrographs of (a) native-oxide covered Ti surface, and MOCVD-grown Ti
d) 360min; and cross sectional views for the compact (e) and columnar (f) structures.ly different P<0.01 (T9 versus T1200) and P<0.001 (T12 versus T1200; T14 versus
is inserted into the human body, the surrounding tissues come
into direct contact with the protective and bioactive oxide layer,
mainly represented by TiO2. Considering that the oxide layer
which forms naturally on titanium is only a few nanometers thick
and presents imperfections, we used the LP-MOCVD technique
to deposit TiO2 layers on flat Ti substrates with the purpose of
O2 films on Ti substrates for different periods of time: (b) 90min; (c) 250min, and
i
a
a
a
s
p
s
d
t
t
r
t
a
w
t
t
a
s
n
s
c
c
c
f
i
h
m
a
f
d
t
e
3
tFig. 2. GIXRD patterns of the TiO2 films deposited on Ti substrate.
mproving the interfacial properties between the gingival tissue
nd the implant. These samples were called T9, T12 and T14
nd they are presented in Table 1 along with their preparative
nd structural characteristics. T1200 is a native-oxide covered Ti
pecimen (Fig. 1a) which was polished with grade 1200 SiC paper
rior to use as a control in cell culture experiments.
SEM micrographs evidenced different film morphologies from
mall (T9: Fig. 1b) to large (T12: Fig. 1c, and T14: Fig. 1d) grained
eposits, depending on the deposition time: the longer the time,
he thicker the film and the larger the crystal size. Big crystal clus-
ers grown here and there over the surface increase the surface
oughness. Even on rough surfaces the films proved conformal, i.e.
hey fit in polishing grooves.
Fig. 1e and f shows the cross sectionalmorphology of samples T9
ndT14. The1mthickdeposit onT14showsacolumnar structure,
hereas the 0.2m thick deposit on T9 shows a compact struc-
ure. This is consistent with a previous study showing that under
he growth conditions listed in Section 2.1, the TiO2 deposit adopts
compact structure as long as the thickness is less than 0.4m or
o, and that a columnar structure forms upon increasing the thick-
ess [26]. T12 is 0.6m thick. Its cross sectional morphology (not
hownonFig. 1) ismadeof a compactundercoat coveredwitha thin
olumnar overlay. The measured water contact angles (Table 1) are
onsistent with the observed morphologies. The high hydrophilic
haracter of samples T12 (contact angle =9◦) and T14 (8◦) comes
rom the micro-porous surface generated by inter columnar spac-
ng. Conversely, the compact structure of T9 results in a far less
ydrophilic surface with a water contact angle of 55◦.
From GIXRD patterns, the films grown on T9, T12 and T14 were
ixtures of crystallized anatase and rutile (Fig. 2). The respective
mounts of anatase and rutile couldnot bemeasuredquantitatively
rom the – patterns, either because intensities were too weak
ue to the thinness of deposit (T9) or because rutile proved 〈200〉
extured (T12 and T14). This is why Table 1 shows but qualitative
valuations..2. Cell viability and cell morphology
An important objective of this study was to determine if the
hin films of TiO2 produced by LP-MOCVD technique affected cel-
Table 2
Comparative evaluation of LDH activity expressed in culture media by HGF-1 c
(T1200) specimens. Data show absorbance values (OD490) averaged from three
times the standard deviations. Mean values are not statistically significantly diff
Specimen Ti-1200 T9
OD490 0.251 (0.003) 0.24lular survival. To test this parameter, the LDH activity in the culture
media was quantified. LDH is a soluble cytosolic enzyme, present
in all cell types, and rapidly released into the cell culture medium
upon damage of the plasma membrane. Therefore, it is the most
widely used marker of cell membrane integrity and serves as a
general means to assess cytotoxicity. HGF-1 cells in contact with
TiO2-coated and native-oxide covered Ti surfaces proved to dis-
play low LDH release in culture medium suggesting that none of
these surfaces exerted cytotoxic effects. Moreover, no significant
differences between the samples were noticed (Table 2).
In culture, the morphology indicates the health status of the
cells. As shown in Fig. 3, at 72h post-seeding, HGF-1 cells were
fully spread, elongated and polygonal shaped, with cytoplasmic
extensions and filopodia, indicating good cell attachment to the
surface. Cell body of the gingival fibroblasts cultured on MOCVD-
coated surfaces (Fig. 3b–d) became increasingly more voluminous
with increased roughness. This could be due to a sparse adsorption
of proteins from culture medium on the surface of oxide crystals.
These protein aggregates represent interaction sites to cells that, in
this situation, extend across large areas adopting a more elongated
and large morphology. On the four surfaces, an intense labeling of
actin cytoskeleton was observed in the entire cytoplasm and bright
fluorescent filiform stress fibers were visible.
3.3. Adhesive cell-biomaterial interactions mediated through
fibronectin matrix
Cell adhesion to a biomaterial surface is, in many cases, a spe-
cial form of cell–ECM interaction, since the biomaterial surface is
always covered by proteins that become adsorbed to this from
either serum within cell culture media, or body fluid within the
in vivo environment. Some of these proteins with which the cells
interact, such as fibronectin and vitronectin, represent very known
ligands for the integrin family of cell adhesion receptors [27].
Integrin-mediated cell adhesion is associatedwith signaling events
and modulation of gene expression that ultimately determine the
following cellular events: proliferation, differentiation and survival
[28]. Inadequate or inappropriate cell–ECM adhesions can lead to
anoikis, a special type of adhesion driven apoptosis [29].
Fibronectin is an abundant component of the ECM consisting of
repeating units of amino acids, which form domains that enable
the molecule to interact with many cell types through both inte-
grin and non-integrin receptors. It is encoded by a single gene,
but alternative splicing of pre-mRNA allows formation of multi-
ple isoforms that regulate adhesion-dependent survival signaling
[30] and play a critical role in cell proliferation and differentiation
[28]. FN binds primary to the51 integrins, through the arginine-
glycine-aspartic acid (RGD) cell-binding site forming a prototypic
integrin–ligand pair [31]. This receptor–ligand pair mediates FN
fibril formation and governs ECM assembly, which is essential to
cell function. During assembly, FN is initially organized into fine
cell-associated fibrils and, through continued accumulation of FN
by synthetic and secretory cell activities, these fibrils are organized
into a dense and stable extracellular fibrillar network. Therefore,
fibronectin organization could be a useful tool to determine the
biocompatibility of dental implants. After 5 days of culture, we
found out a different distribution pattern of this protein over ana-
lyzed surfaces (Fig. 4). Thus, removal and reorganization of FN
ells in contact with TiO2 coated (T9, T12, T14) and native-oxide covered
measurements by specimen. Experimental errors are expressed as three
erent P>0.05 (T9, T12 and T14 versus T1200).
T12 T14
9 (0.001) 0.254 (0.001) 0.258 (0.001)
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Tig. 3. Morphology of HGF-1 cells attached to: (a) native-oxide covered Ti surface, a
f cytoskeleton (FITC-conjugated phalloidin).rom the material surfaces into ECM like structures occurred on
oderatelywettable surfaces T1200 (Fig. 4a) and T9 (Fig. 4b). How-
ver, fibrillar FN network was better expressed on T9 than on
he non-CVD-coated T1200 sample. The latter shows less fibril-
ig. 4. Indirect immunolocalization of fibronectin adsorbed to and secreted by HGF 1 cel
9, (c) T12, and (d) T14.CVD-TiO2 coated specimens: (b) T9, (c) T12, and (d) T14. Fluorescent actin staininglar structures and veil-like FN zones indicating a non-uniformous
removal/reorganization of FN adsorbed to and secreted on the
material surface. On the more hydrophilic surfaces (T12 and T14),
the background was majoritary FN immunostained and very few
ls on: (a) native-oxide covered Ti surface, and MOCVD-TiO2 coated specimens: (b)
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fer a moderately rough surface, the optimal Ra value being around
0.70 (the case of T9 and T12 samples). In the literature, cellular
adhesion and cell proliferation have been shown to be sensitive to
surface roughness [18,38,39]. For example, in their study on the
effect of surface topography and composition on cellular responseig. 5. Immunofluorescent detection of proliferative cells after BrdU incorporation
uclei, on: (a) native-oxide covered Ti surface, and MOCVD-TiO2 coated specimens
brils assembled (Fig. 4c and d). This suggests that the cells were
ssentially unable to reorganize FN into an ECM-like structure on
he material surface.
Our results confirm the influence of surface wettability on
he interactions of the cellular substrate with proteins and fur-
her on cell behavior. It is a general trend that mammalian cells
nteract better with hydrophilic (wettable) surfaces than with
ydrophobic (non-wettable) surfaces [32–34]. In fact, the wetta-
ility of the surface may affect cell attachment either directly,
ince the attachment phase as an initial process involves physic-
chemical interactions between cells and surfaces including ionic
orces or indirectly through alterations in the adsorption pro-
ess of conditioning molecules, such as proteins. On the contrary,
ther authors reported that cells adhere better on moderately
ydrophobic surfaces with water contact angles of around 70◦
35–37]. These conflicting results may be due to the use of materi-
ls characterized by different surface topographic parameters such
s roughness and micro-texture, and especially different surface
hemistry that affect the material wetting behavior. In the present
tudy, the most suitable TiO2-coated substrate, in terms of FN fib-
il assembly that becomes incorporated into a stable ECM is T9.
his sample is characterized by a moderately wettable (water con-
act angle =55◦) and rough (Ra = 0.71m) MOCVD-deposited TiO2
lm.
.4. Assessment of cell proliferation status
To definitively assess the biocompatibility of the native-oxide
overed and TiO2-coated Ti substrates, we addressed the rela-
ionship between the properties of analyzed surfaces and cell
roliferation. A comparative approach of cell cycle analysis by
rdU incorporation into chromosomal DNA of the S-phase cells
Fig. 5) and PCNA Western blotting assay (Fig. 6) provided valuable
nformation about the proliferation status of HGF-1 cells grown in
ontact with the specimens.ing the cells that undergo DNA synthesis, as indicated by presence of green bright
9, (c) T12, and (d) T14.
As shown in Fig. 5, the highest density of fluorescent nuclei was
observed on the MOCVD-treated T9 sample (Fig. 5b). A lower num-
ber of S-phase cells were remarked on the non-treated disc, T1200
(Fig. 5a)with relatively smooth (Ra = 0.35m)andmoderatelywet-
table (contact angle =60◦) surface. Samples T12 (Fig. 5c) and T14
(Fig. 5d) having highly hydrophilic TiO2 deposits and different sur-
face roughness displayedmuch less labeled cells.Most importantly,
Western blot analysis of PCNA demonstrates that the intensity of
the band corresponding to PCNAprotein (∼36kDa) decreases in the
following order: T9>T1200=T12>T14 (Fig. 6).
Taking together, BrdU immunocytochemistry and Western blot
data, we conclude that the proliferation capacity of HGF-1 cells
decreases in the following order: T9>T1200>T12>T14. Therefore,
the cell proliferation appears to run in parallel with the quality of
FN-mediated cell adhesion and is sensitive to surface wettability.
Comparison of cell proliferation potential between samples with
quasi-similar water contact angle values but of different rough-
ness, namely T1200/T9 ononehand and T12/T14 on the other hand,
demonstrated that surface roughness could represent a secondary
determinant of cell behavior. Thus, HGF-1 cells have proved to pre-Fig. 6. Western blotting detection of PCNA expression in lysates of the cells grown
in contact with native-oxide covered Ti surface (lane 2), and MOCVD-TiO2 coated
specimens: T9 (lane 3), T12 (lane 4), and T14 (lane 5). MW=high molecular weight
marker (lane 1).
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[ig. 7. Gelatin-zymographic determination of the MMP secreted by HGF-1 cells
aintained in contact for 72h with: native-oxide covered Ti surface (lane 2), and
OCVD-TiO2 coated specimens: T9 (lane 3), T12 (lane 4), and T14 (lane 5).MW-high
olecular weight marker (lane 1).
f human gingival fibroblasts grown on NiTi substrates, Ponsonnet
t al. [39] demonstrated that there might exist a roughness thresh-
ld (between 0.08 and 1m) over which cell proliferation became
ifficult and that the lowest cell proliferation occurred on the NiTi
urfaces of the highest roughness.
.5. MMP gelatinolytic activities expressed in cell culture media
It is recognized that cell–biomaterial interface in vitro differs
ubstantially from the periimplant environment in vivo where
mplant failure can be attributed to several factors such as biolog-
cal, microbiological and biomechanical [40]. However, the exact
olecular mechanisms of implant failure are not well known. The
oosening of implants used in dentistry and orthopedic surgery
ave been shown to involve proteolytic cascades and MMPs
41–43]. MMPs are a group of structurally related but geneti-
ally distinct endopeptidases that have the capacity to degrade all
CM and basement membrane components [44]. These enzymes
re secreted especially by osteoclasts and gingival inflammatory
nfiltrate and, at high concentrations, they contribute to the resorp-
ion/osteolysis and to soft tissue/dental ligament destruction [45].
Considering that interaction with inadequate substrates could
nduce the cells to synthesizeMMPs and eventually detach [28], we
valuated the gelatinolytic activities specific for theMMPs secreted
n the conditioned culturemedia byHGF-1 cellsmaintained in con-
act with the analyzed specimens for 72h. As shown in Fig. 7, in all
nalyzedmedia, thegelatinolytic activitiesweredetectedat72kDa,
6 kDa and ∼190kDa corresponding to proMMP-2, proMMP-9
nd MMP-dimers respectively. In addition, a barely visible addi-
ional gelatinolytic band, corresponding to the active MMP-2 form
68kDa),waspresent ineachprofile. Theseactivitiesdisappeared in
hepresenceof 10mM1,10-phenantroline (datanot shown).MMP-
represents a MMP member which is constitutively expressed by
any cell types, being associated with physiological tissue remod-
lling at low levels of expression, while MMP-9 is mainly involved
n inflammatory conditions.
The gelatinolytic activities corresponding to proMMP-9 and
specially proMMP-2 were lower for the MOCVD-coated surfaces
han for the native-oxide covered surface. These results suggest
hat in vivo integration of native-oxide covered Ti implants would
e more problematic than that of TiO2 MOCVD-coated Ti implants.
aking into account that the intensities of the gelatinolytic bands
orresponding to proMMP-2 and proMMP-9 decreased in the fol-
owing order: T14>T12>T9, we can suppose that the thickness
nd crystal size of the TiO2 coatings obtained by MOCVD repre-
ent themain surface characteristic of implantmaterial influencing
ellular capacity to degrade ECM. In addition, we cannot currently
ule out the possibility that other film structural parameters such
s roughness, transversal morphology, allotropic composition and
ettability contribute to the proteolytic events at material-tissue
nterface. Therefore, we intend to go deeply into this study and
omplete it with studies on other MMP members known to be
nvolved in implant failure.
[
[
[Actually, a longsurvival of adental implant iswarrantednotonly
by a good osseintegration but also by the presence of an adequate
zone of attached gingiva surrounding the implant. The overexpres-
sion of MMPs by gingival fibroblasts could be responsible for the
reduction in the thicknessof theentire gingival soft tissueandof the
keratin layer in peri-implantmucosa. As a result of these processes,
the products from the oral cavity and peri-implant pocket eas-
ily penetrate the peri-implant mucosa. This situation may explain
the presence of very high numbers of inflammatory cells around
loosened dental implants [46].
The lowest MMP activity expressed in cell culture media by
HGF-1 cells grown in contact with T9 recommends this LP-MOCVD
prepared thin TiO2 film as being able to induce the best tissues
integration in comparison with the other LP-MOCVD TiO2-coated
Ti samples.
4. Conclusions
In this study, we have confirmed that the LP-MOCVD technique
is well adapted to modifying the surface of materials used in den-
tal implantology. The present in vitro findings indicate that this
technique can provide TiO2 covered titanium implants with supe-
rior qualities in terms of FN organization into fibrillar structures,
proliferation and host tissue integration capacity. According to our
experimental data, the major factors that proved to govern these
important biological events for cell–material interactions, are the
wettability and, secondarily, the roughnessof theoxide surface. The
most suitable substrate for the cellular model used in this study is
characterized by a moderately rough and wettable TiO2 film.
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